Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.

@article{Gridelli2009VaccinesFT,
  title={Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.},
  author={Cesare Gridelli and Antonio Rossi and Paolo Maione and Marianna Luciana Ferrara and Vincenzo Castaldo and Paola Claudia Sacco},
  journal={The oncologist},
  year={2009},
  volume={14 9},
  pages={909-20}
}
Carcinoma of the lung is the leading cause of cancer death worldwide, with non-small cell lung cancer (NSCLC) constituting about 85% of all new diagnoses. Standard approaches for each NSCLC stage have reached a plateau in effectiveness. A variety of novel approaches are now being investigated to improve the outcome of this disease. Despite decades of research, no specific active cancer vaccine has, to date, been approved for NSCLC therapy; nevertheless, vaccine therapy has recently re-emerged… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 44 extracted citations

Cancer vaccines: harnessing the potential of anti-tumor immunity.

Veterinary journal • 2013
View 2 Excerpts
Highly Influenced

What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer?

Annals of oncology : official journal of the European Society for Medical Oncology • 2012
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…